We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.45%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$24.5B
AUM Growth
-$766M
(-3%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
14.99%
Holding
4,039
New
907
Increased
1,143
Reduced
1,068
Closed
874
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$208M |
| 2 |
CVS Health
CVS
|
+$132M |
| 3 |
Comcast
CMCSA
|
+$114M |
| 4 |
Honeywell
HON
|
+$94.8M |
| 5 |
ConocoPhillips
COP
|
+$92.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$233M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$228M |
| 3 |
Apple
AAPL
|
+$195M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$157M |
| 5 |
Nike
NKE
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.7% |
| 2 | Consumer Discretionary | 10.58% |
| 3 | Healthcare | 6.83% |
| 4 | Industrials | 5.75% |
| 5 | Financials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Alaunos Therapeutics
TCRT
$4.74M
| $67.2K | ﹤0.01% |
711
+634
| +823% | +$60.4K |
|
3027
Sera Prognostics
SERA
$80.3M
| $65.4K | ﹤0.01% |
+17,064
| New | +$44.8K |
|
3028
OraSure Technologies
OSUR
$273M
| $64.7K | ﹤0.01% |
10,686
-754
| -7% | -$4.26K |
|
3029
Sensus Healthcare
SRTS
$49.9M
| $62.5K | ﹤0.01% |
+11,989
| New | +$86.1K |
|
|
URG
3030
Ur-Energy
URG
$485M
| $61.1K | ﹤0.01% |
+57,619
| New | +$65.1K |
|
|
FINV
3031
FinVolution Group
FINV
$1.12B
| $60.7K | ﹤0.01% |
+14,556
| New | +$73.6K |
|
|
LEV
3032
DELISTED
The Lion Electric Company
LEV
| $60K | ﹤0.01% |
32,254
+910
| +3% | +$2.06K |
|
3033
Sutro Biopharma
STRO
$379M
| $59.8K | ﹤0.01% |
+1,295
| New | +$82.2K |
|
3034
Coeur Mining
CDE
$15.6B
| $59.7K | ﹤0.01% |
14,961
-273,899
| -95% | -$951K |
|
3035
BigBear.ai
BBAI
$1.32B
| $59K | ﹤0.01% |
+24,175
| New | +$64.4K |
|
|
EMKR
3036
DELISTED
Emcore Corp
EMKR
| $58.8K | ﹤0.01% |
+5,117
| New | +$62.4K |
|
|
FSP
3037
Franklin Street Properties
FSP
$44.8M
| $58.5K | ﹤0.01% |
37,271
-64,182
| -63% | -$161K |
|
3038
VirnetX Holding Corp
VHC
$52.3M
| $58.2K | ﹤0.01% |
2,222
+1,462
| +192% | +$47.3K |
|
3039
Lexicon Pharmaceuticals
LXRX
$1.02B
| $58.2K | ﹤0.01% |
23,938
-3,326
| -12% | -$7.62K |
|
|
EQRX
3040
DELISTED
EQRx, Inc. Common Stock
EQRX
| $57.9K | ﹤0.01% |
+29,870
| New | +$68K |
|
3041
American Resources Corp
AREC
$186M
| $57.6K | ﹤0.01% |
+38,368
| New | +$57.4K |
|
|
NTCO
3042
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $57.4K | ﹤0.01% |
11,000
-3,540
| -24% | -$18.7K |
|
3043
Spruce Power Holding Corp
SPRU
$39.9M
| $56.9K | ﹤0.01% |
+8,677
| New | +$74.2K |
|
3044
Nordic American Tanker
NAT
$1.37B
| $56.1K | ﹤0.01% |
14,172
-18,838
| -57% | -$67.6K |
|
3045
Opko Health
OPK
$921M
| $54.8K | ﹤0.01% |
37,518
-20,147
| -35% | -$25.9K |
|
3046
Harvard Bioscience
HBIO
$27.1M
| $54.6K | ﹤0.01% |
1,299
+236
| +22% | +$7K |
|
3047
Compass Therapeutics
CMPX
$373M
| $53.2K | ﹤0.01% |
+16,263
| New | +$63.9K |
|
|
NXDR
3048
Nextdoor Holdings
NXDR
$835M
| $52.9K | ﹤0.01% |
24,599
-2,979
| -11% | -$6.36K |
|
3049
Pixelworks
PXLW
$38.8M
| $52.2K | ﹤0.01% |
+2,937
| New | +$61.9K |
|
3050
Puma Biotechnology
PBYI
$406M
| $52.1K | ﹤0.01% |
16,850
-1,043
| -6% | -$3.93K |
|
Similar funds
Squarepoint's Q1 2023 Portfolio in Review
As of Q1 2023, Squarepoint held 4,039 positions worth $24.5B, down 3% from $25.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $1.16B of net new capital in Q1 2023, opening 907 new positions and adding to 1,143 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street Materials Select Sector SPDR ETF, an estimated $233M trimmed.
- Squarepoint's largest Q1 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
- Squarepoint added most to CVS Health in Q1 2023, an estimated $132M increase.
- Squarepoint's biggest Q1 2023 reduction was State Street Materials Select Sector SPDR ETF, cutting an estimated $233M.
- Squarepoint fully exited Mondelez International in Q1 2023, selling an estimated $95.9M.
- Squarepoint's ten largest holdings make up 15% of its $24.5B portfolio in Q1 2023.
- Squarepoint opened 907 new positions and closed 874 in Q1 2023.
- Squarepoint's portfolio value fell 3% quarter-over-quarter to $24.5B.
Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.